Info

Phase 0 Trials

  • Administration of single or several doses (<7 d), often subtherapeutic, of the study drug to a small number of subjects

  • Includes correlation w/biomarkers/imaging & gathering of preliminary data on PK and PD; gives no data on safety or efficacy